 |
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1904597
線上人數 : 367
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/29316
|
| 題名: | Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement |
| 作者: | Yang, CC;Chu, KC;Yeh, WM |
| 貢獻者: | 附設醫院泌尿部;China Med Coll Hosp, Dept Urol, China Med Coll, Taichung 404, Taiwan;China Med Coll Hosp, Dept Pathol, China Med Coll, Taichung 404, Taiwan;China Med Coll, Peikang Hosp, Dept Urol, Peikang, Taiwan |
| 日期: | 2003 |
| 上傳時間: | 2010-09-24 14:31:48 (UTC+8) |
| 出版者: | WILEY-LISS |
| 摘要: | An in vitro bone cell culture model was used to evaluate the potential application of sintered beta-dicalcium pyrophosphate (SDCP) in arthroplasty surgery. Primary osteoclasts and osteoblasts were cocultured with different sizes of SDCP particles. The changes in cell counts and the synthesis and secretion of alkaline phosphatase, acid phosphatase, and prostaglandin E-2 in response to the SDCP particles were monitored. When bone cells were cultured with SDCP particles smaller than 53 mum, both the osteoblast and osteoclast cell counts decreased significantly. When the SDCP particles were larger than 177 mum, although the osteoblast population increased significantly, the osteoclast population decreased significantly. Simultaneously, the titer of prostaglandin E-2 in the medium and the cytoplasmic prostaglandin E-2 increased significantly. We concluded that SDCP is a potentially useful bioceramic for the prevention of osteoclast-mediated periprosthetic osteolysis. |
| 關聯: | JOURNAL OF CLINICAL LABORATORY ANALYSIS 17(3):85-89 |
| 顯示於類別: | [台中附設醫院] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
